➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
McKesson
McKinsey
AstraZeneca
Express Scripts
Mallinckrodt

Last Updated: November 26, 2020

DrugPatentWatch Database Preview

PHENTOLAMINE MESYLATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Phentolamine Mesylate patents expire, and when can generic versions of Phentolamine Mesylate launch?

Phentolamine Mesylate is a drug marketed by Precision Dose Inc and West-ward Pharms Int and is included in two NDAs.

The generic ingredient in PHENTOLAMINE MESYLATE is phentolamine mesylate. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the phentolamine mesylate profile page.

US ANDA Litigation and Generic Entry Outlook for Phentolamine Mesylate

A generic version of PHENTOLAMINE MESYLATE was approved as phentolamine mesylate by WEST-WARD PHARMS INT on March 11th, 1998.

  Start Trial

Drug patent expirations by year for PHENTOLAMINE MESYLATE
Drug Prices for PHENTOLAMINE MESYLATE

See drug prices for PHENTOLAMINE MESYLATE

Recent Clinical Trials for PHENTOLAMINE MESYLATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Missouri-ColumbiaEarly Phase 1
Ocuphire Pharma, Inc.Phase 2
Cambridge University Hospitals NHS Foundation TrustPhase 1

See all PHENTOLAMINE MESYLATE clinical trials

Pharmacology for PHENTOLAMINE MESYLATE
Medical Subject Heading (MeSH) Categories for PHENTOLAMINE MESYLATE

US Patents and Regulatory Information for PHENTOLAMINE MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Precision Dose Inc PHENTOLAMINE MESYLATE phentolamine mesylate INJECTABLE;INJECTION 207686-001 Jul 14, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int PHENTOLAMINE MESYLATE phentolamine mesylate INJECTABLE;INJECTION 040235-001 Mar 11, 1998 AP RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
AstraZeneca
Boehringer Ingelheim
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.